Literature DB >> 6231978

The dopamine/neuroleptic receptor.

D Grigoriadis, P Seeman.   

Abstract

The neuroleptic/dopamine receptor, with its picomolar affinity for potent neuroleptics, is the functional dopamine receptor of the brain. This receptor has been termed the D2 dopamine receptor, and it inhibits or interferes with dopamine-stimulated adenylate cyclase. This D2 receptor has two states, each having different affinity for dopamine. The high-affinity state, termed D2 high, has a 10 nM affinity for dopamine and is the functional correlate for dopamine autoreceptors and for the dopamine receptor in the pituitary gland. The low-affinity state, termed D2 low, has a 2000 nM affinity for dopamine, and may possibly represent the desensitized state of the dopamine receptor or the functional post-synaptic receptor.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6231978     DOI: 10.1017/s0317167100046242

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  10 in total

1.  Effects of stimulation and blockade of dopamine receptor subtypes on the discriminative stimulus properties of cocaine.

Authors:  R L Barrett; J B Appel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 2.  Recent advances in receptor research.

Authors:  M Schachter
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

Review 3.  Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.

Authors:  G B Baker; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1989-03       Impact factor: 5.046

4.  Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.

Authors:  A M Zarkovsky; K S Cereska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

5.  Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (-)-3-PPP.

Authors:  S R George; M Watanabe; P Seeman
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 6.  Dopamine-receptor agonists: mechanisms underlying autoreceptor selectivity. I. Review of the evidence.

Authors:  D Clark; S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

Review 7.  Parkinson's disease in 1984: an update.

Authors:  A E Lang; R D Blair
Journal:  Can Med Assoc J       Date:  1984-11-01       Impact factor: 8.262

8.  [3H]-domperidone labels only a single population of receptors which convert from high to low affinity for dopamine in rat brain.

Authors:  D Grigoriadis; P Seeman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

9.  Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis.

Authors:  F Brown; W Campbell; P J Mitchell; K Randall
Journal:  Br J Pharmacol       Date:  1985-04       Impact factor: 8.739

10.  Synthesis and radioreceptor binding activity of N-0437, a new, extremely potent and selective D2 dopamine receptor agonist.

Authors:  A S Horn; P Tepper; J Van der Weide; M Watanabe; D Grigoriadis; P Seeman
Journal:  Pharm Weekbl Sci       Date:  1985-10-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.